Flexion Therapeutics — Q4 2020 Earnings Presentation
7 slides from Flexion Therapeutics's earnings presentation, Jan 13, 2021
Slide 1: Q4 2020 Commercial Metrics
Q4 2020 Commercial Metrics January 13, 2021 Exhibit 99.2
Slide 2: Overview
Overview 2 Preliminary ZILRETTA® net sales of ~$26.3 million in Q4 2020 Net sales for full-year 2020 estimated to be ~$85.5 million 4,248 accounts had purchased ZILRETTA as of December 31, 2020; up from 4,072 as of September 30, 2020 3,321 accounts had re-ordered ZILRETTA (78% of accounts that had p
Slide 3: ZILRETTA Net Sales Quarterly Since Launch
ZILRETTA Net Sales Quarterly Since Launch 3 Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies.
Slide 4: Distribution of Accounts by ZILRETTA Purchases
Distribution of Accounts by ZILRETTA Purchases Cumulative 4 Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics, and certain medical centers or hospitals) subsequently purchase ZILRETTA from these specialty distributors and the specialty
Slide 5: Distribution of ZILRETTA Purchases by Accounts
5 Distribution of ZILRETTA Purchases by Accounts Cumulative Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics, and certain medical centers or hospitals) subsequently purchase ZILRETTA from these specialty distributors and the specialty
Slide 6: ZILRETTA Purchases by New and Existing Accounts
ZILRETTA Purchases by New and Existing Accounts Cumulative 6 Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics, and certain medical centers or hospitals) subsequently purchase ZILRETTA from these specialty distributors and the specialt
Slide 7: Flexion: Transformative Medicine... Where It Matters
clevion Transformative Medicine... Where It Matters